Company intelligence / Profile preview
Crescent Innovations
Westford, Massachusetts, United States
- Ownership
- Private
- Employees
- ~2
- Development stage
- Other
01
Overview
Developed and clinically validated a patented, site-specific injectable hydrogel formulation for bone regeneration using prostaglandin E1, demonstrated in vivo to induce bone growth without off-target ossification. Technology and associated IP are being offered for sale as of 2024.
- Therapeutic areas
- OtherNeurologyEndocrinologyRheumatology
- Modalities
- Hydrogel-based drug delivery therapySmall molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Crescent Innovations.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Crescent Innovations.